Dr Chris Jolly
|
Research Fellow
C39 - Royal Prince Alfred Hospital |
|
On this page
Themes | Biographical details | Research interests | Teaching areas | Grants | Honours project opportunities | Keywords
Biographical details
PhD: Macquarie University/CSIRO, Sydney - 1993 [More...]
Research interests
My group studies antibody mutation in activated B cells, which is initiated by the DNA editing enzyme "AID". B cells mutate their antibody genes at extremely high rates during infections, to rapidly optimise the ability of the antibodies they make to neutralise the infecting pathogen. "Off-target" many adult B cell cancers, so we seek to understand why AID-induced DNA damage leads to mutation, when similar DNA damage is generally repaired faithfully.
Teaching areas
B cell development. Antibody gene rearrangement and mutation.
Current national competitive grants*
2011
Regulation of the quality of DNA repair by timing in the cell cycle
Jolly C
National Health and Medical Research Council Project Grant ($452,957 over 3 years)
* Grants administered through the University of Sydney
Honours project opportunities
Cell cycle regulation of DNA damage and repair in activated B cells
Screening for drugs to inhibit AID, a key contributor to B cell neoplasia
Mapping translocations in pre-cancerous human B cells
